Signature Estate & Investment Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History
Signature Estate & Investment Advisors LLC
- $3.94 Billion
- Q4 2024
A detailed history of Signature Estate & Investment Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Signature Estate & Investment Advisors LLC holds 327 shares of REGN stock, worth $243,559. This represents 0.01% of its overall portfolio holdings.
Number of Shares
327
Previous 298
9.73%
Holding current value
$243,559
Previous $313,000
25.88%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,492Shares Held
85.8MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.92 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.29 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$5.26 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.6 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.53 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $79.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...